Nuplex Industries' independent directors are unanimously backing Allnex Belguim SA's $1.05 billion bid for the resins maker after the US-based firm completed its due diligence.
The companies have signed a scheme implementation agreement, which values Nuplex at $5.55 a share, including the 12 cents per share dividend payment in February. That's a 44 per cent premium to where the shares were trading before the February 15 announcement and higher than the current price of $5.26, which gained 3.5 per cent at today's open. Nuplex's directors all support the bid, which requires 75 per cent approval in a special meeting likely to be held in August.
The recommendation is contingent on the $5.43 offer price, which excludes the dividend, falling within or above the independent adviser's valuation range, and that a better offer doesn't emerge. Managing director Emery Severin abstained from making a recommendation because of his executive role.
"The board believes Nuplex is well positioned to deliver growth in earnings, particularly from the platform now established in Asia and our new breakthrough technology, Acure," chairman Peter Springford said in a statement.
"However, delivering this growth will take some time and therefore shareholders may find attractive the opportunity to realise some of the future value of their Nuplex shares in cash now."